Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: March 2013

With Federal Funding Being Cut, Rally for Medical Research Set for April 8 in DC

Washington, DC, March 29, 2013 — Federal funding for medical research continues to decline, threatening the future health of Americans, and organizers of the Rally for Medical Research are working to shine the spotlight on the problem.

Organizers are rallying the nation’s research community to attend — in person or via the Web — a Rally for Medical Research.  The rally will be held Monday, April 8 from 11 a.m. to 12:15 p.m. (ET) in Washington, DC at the Carnegie Library Grounds at Mt. Vernon Square (801 K Street, NW). Continue reading

NJ State Library Adds US Small Business Administration and NJ Business Action Center for ‘Grow NJ Business Strong’ Events

Trenton, NJ, March 28, 2013 — The New Jersey State Library is hosting a series of business marketing workshops for small business owners and aspiring entrepreneurs to detail the many resources available in NJ to help businesses grow and thrive.  

The free, two-hour workshops will take place at library locations across the state, April 2 through May 16, and provide a continental breakfast.

According to Mary Chute, New Jersey State Librarian, “The goal of the Grow NJ Business Strong event series is to provide tips and techniques for best practices in business marketing, and also raise awareness of the useful resources for business planning and research available at no direct cost to businesses at NJ’s local public libraries and various state agencies.” Continue reading

NJ Health Commissioner Mary O’Dowd Tops NJBIZ Health Care ‘Power 50’

Somerset, NJ, March 26, 2013— NJBIZ has published its annual listing of New Jersey’s health care “Power 50.”  At the top of its 2013 Power 50 list is New Jersey Commissioner of Health and Senior Services Mary O’ Dowd. 

“We’re going at warp speed, on roads we’ve never been down, and no one knows where we’re going,” is how one executive summarized the state of hospitals and health care for NJBIZ. Continue reading

NJ Tech Weekly: Can Tech Industry and Universities Work Jump-Start Innovation?

West Caldwell, NJ, March 26, 2013 — As Esther Surden reports in New Jersey Tech Weekly, the good news is:  intellectual property (IP) — in the form of patents on everything from life sciences discoveries to digital technology — originates at New Jersey’s universities on a frequent basis.  

The bad news is:  It is often difficult for entrepreneurs to acquire this knowledge and “run with it” to create a product or service that will start an industry, or even just a solid great company, here in New Jersey.

Surden writes that many of the barriers are culture-related and stem from differing points of view in academia and industry.  However, a new report focuses on how academia, industry and the state can work together to address many of the issues that challenge greater, more successful collaboration between the Garden State’s higher-education institutions and the private sector. Continue reading

Mayor Janice Mironov: ‘How the Biomedical Industry Bolsters NJ’

East Windsor, NJ, March 22, 2013 — In an op-ed published in The Record, the Honorable Janice Mironov, Mayor of East Windsor Township and President of the New Jersey State League of Municipalities, writes, “[T]his state’s biomedical industry is a shining example of an investment paying good dividends to New Jersey’s workers, investors and taxpayers.  Recognizing this reality, we have created the Mayors Committee on Life Sciences, a partnership between the New Jersey State League of Municipalities and We Work for Health New Jersey.”

Mayor Mironov says, “[Life sciences’] jobs extend well beyond the walls of research and development campuses and manufacturing facilities.  Biopharmaceutical companies rely on deep supply chains that extend benefits throughout the community.” Continue reading

FDU to Host Seminar for NJ Businesses on ‘Doing Business in Korea’

Teaneck, NJ, March 22, 2013 — Fairleigh Dickinson University’s Office of Global Learning will host a morning seminar on how New Jersey businesses can build their international markets in Korea.

The seminar, “Doing Business in Korea,” will be held Thursday, April 4 from 8:30 a.m. to noon at the Student Union of FDU’s Metropolitan Campus in Teaneck, NJ. Continue reading

Senate Votes to End Medical Device Tax

Washington, DC, March 22, 2013The Hill reports that the United States Senate on Thursday approved a bipartisan budget amendment calling for the end of a medical device tax enacted as part of President Obama’s Affordable Care Act.

However, the budget resolution is not binding, so even if the Senate resolution is reconciled with a competing House version, the device tax would still be in effect. Continue reading

House Health Subcommittee Leaders Preview Life Sciences Priorities

Washington, DC, March 22, 2013 — Elise Viebeck reports in The Hill that the leaders of the House Energy and Commerce Committee’s Health Subcommittee have vowed to bring fresh life sciences debates to the fore in the current Congress. 

Reps. Joe Pitts (R-PA) and Michael Burgess (R-TX), the respective chairman and vice-chairman of the Health Subcommittee, said they intended to be “more pro-active with our messaging,” particularly on issues concerning the FDA.  Continue reading

Celgene’s Robert Hugin Says ‘Medical Innovation Is a Crown Jewel of America’

Summit, NJ, March 21, 2013 — In a speech touching on the biopharmaceutical industry, innovation, the economy and policy, Robert J. Hugin, Chairman & Chief Executive Officer of Celgene Corporation and former HealthCare Institute of New Jersey Chair, said “medical innovation is a crown jewel of America,” adding that it has “contributed so greatly to the success of our country over the last 50 years and has made such a meaningful difference in the quality and length of our lives.”

Speaking at a U.S. Food & Drug Administration and the Centers for Medicare & Medicaid Services summit entitled “Medical Innovation and Public Policy: At the Crossroads” on December 11, 2012, Mr. Hugin told his audience, “It is paramount that we work together to ensure that policymakers … recognize that a positive policy environment is actually a critical part of the solution in dealing with these many challenging issues that we all face.” Continue reading

PhRMA Report: 465 Medicines in Development for Chronic Diseases Affecting Seniors

Washington, DC, March 21, 2013 — America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditions affecting seniors, according to a new report and overview released yesterday by the Pharmaceutical Research and Manufacturers of America (PhRMA).

 With the population of Americans over 65 on the rise and life expectancy climbing, chronic diseases remain a principal threat to the health and productivity of older Americans, as well as to rising health care costs.  Innovative medicines have led to major advances against many chronic diseases ― and the robust discovery pipeline of new medicines portends continued progress for seniors and our health care system. Continue reading